Reformulation. As of the Effective Date, Xxxxxx shall not distribute, sell or offer for sale Products in California unless (a) the Products contain no more than 100 parts per million (0.01%) of lead (“Reformulated Products”), or (b) the Products are distributed, sold, or offered for sale with a clear and reasonable warning as described below in Section 2.2.
Reformulation. Dyax shall remain responsible for any activities relating to the reformulation of the Product, including those that are conducted in connection with the EMA approved Pediatric Investigational Plan.
Reformulation. We reformulate the collision avoidance constraints as
Reformulation. As of the Effective Date, Daiso shall not distribute, sell or offer for sale Products in California unless (a) the Products produce a test result no higher than 1.0 microgram of Lead based on a wipe sample collected using NIOSH Method 9100 or equivalent from the part of the Product that constitutes the Exterior Decorations (“Reformulated Products”), or (b) the Products are distributed, sold, or offered for sale with a clear and reasonable warning as described below in Section 2.2. “
Reformulation. As of the Effective Date, Harbor Freight shall not manufacture or distribute the Products for sale in California unless (a) the Products contain no more than 1,000 parts per million (0.1%) of DEHP, DBP, or DINP, and no more than 100 parts per million (0.01%) of Lead (“Reformulated Product”), or (b) the Product is distributed, sold, or offered for sale with a clear and reasonable warning as described below in Section 2.2. The only Products excluded from this requirement are those that have already been distributed to California retailers as of October 31, 2020
Reformulation. As of the Effective Date, Travel Plus shall not distribute, sell or offer for sale the Products in California unless (a) the Products contain no more than 1,000 parts per million (0.1%) of DEHP (“Reformulated Product”), or (b) the Products is distributed, sold, or offered for sale with a clear and reasonable warning as described below in Section 2.2.
Reformulation. In addition to the obligation to warn under Section 2.3, Invacare represents it has begun reviewing the option to reformulate under Section 2.2 to meet a concentration limit of 1000 parts per million (0.1%) for DEHP in all accessible components of the Products manufactured, imported or sold in California on and after the Compliance Date subject to commercial feasibility. For purposes of this Section 2.2, commercial feasibility refers to the following material factors: (1) the availability of other materials that do not incorporate other substances regulated under Proposition 65 (“New Materials”); (2) performance characteristics, including efficacy, durability, and stability, of any New Materials or the resulting product; (3) the availability and reliability of the supply of New Materials; and (4) whether there are any material cost considerations for the use of New Materials. If Invacare’s reasonable efforts lead to the commercial feasibility to meet the reformulation standard referenced in Section 2.2.2 for a subset of Products, Invacare may elect to reformulate such products.
Reformulation. As of the Effective Date, Emperia shall not distribute, sell or offer for sale Products in California unless (a) the Products contain no more than 1,000 parts per million (0.1%) of DEHP (“Reformulated Products”), or (b) the Products are distributed, sold, or offered for sale with a clear and reasonable warning as described below in Section 2.2.
Reformulation. As of the Effective Date, Zoetop shall not distribute, sell or offer for sale the Products in California unless (a) the Products contain no more than 1,000 parts per million (0.1%) of DEHP or DBP, and no more than 200 parts per million of Lead (“Reformulated Product”), or (b) the Product is distributed, sold, or offered for sale with a clear and reasonable warning as described below in Section 2.2.
Reformulation. Beginning on the Compliance Date, Sunwarrior shall not manufacture, supply or distribute, for sale or use in the State of California, any Covered Product that, when placed into individual packaging units for sale to consumers in California, exposes a person to a “Daily Lead Exposure Level” of more than 0.5 micrograms of lead per day unless such Covered Product complies with the warning requirements of Section 2.2. As used in this Section 2, “to distribute” for sale or use in California means to directly ship Covered Products into California or to sell Covered Products to a distributor Sunwarrior knows will sell Covered Products in California.
